Literature DB >> 2550552

Integration of the transposon-like element ETn upstream of V lambda 2 in the cell line P3X63Ag8.

S Weiss1, B Johansson.   

Abstract

The cell line P3X63Ag8 and hybridomas obtained with it contain two rearranged V lambda 2 EcoRI fragments--6.8 kb and 7.4 kb in size. Southern blot analysis, molecular cloning, and mapping revealed that the rearrangements are related to one another and are not due to normal VJ joining. Sequence analysis indicated that the rearrangement was due to the integration of the transposon like element ETn upstream of V lambda 2. Because a normal embryonic V lambda 2 is still retained in this cell line one of the rearranged fragments must be due to a secondary event after the aneuploidization of the plasmacytoma. RNA dot blot analysis showed that the transposon is strongly expressed not only in embryonic cells but also in plasmacytomas, B lymphomas and T cell lines.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2550552

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  5 in total

1.  Novel mouse type D endogenous proviruses and ETn elements share long terminal repeat and internal sequences.

Authors:  D L Mager; J D Freeman
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

2.  Sequence at insertion site of E.Tn retrotransposon into an immunoglobulin switch region suggests a role for switch recombinase.

Authors:  L A Elenich; W A Dunnick
Journal:  Nucleic Acids Res       Date:  1991-01-25       Impact factor: 16.971

3.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1990-02-11       Impact factor: 16.971

4.  Autoimmune disease in mice due to integration of an endogenous retrovirus in an apoptosis gene.

Authors:  J Wu; T Zhou; J He; J D Mountz
Journal:  J Exp Med       Date:  1993-08-01       Impact factor: 14.307

5.  The defect in Fas mRNA expression in MRL/lpr mice is associated with insertion of the retrotransposon, ETn.

Authors:  J L Chu; J Drappa; A Parnassa; K B Elkon
Journal:  J Exp Med       Date:  1993-08-01       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.